MiNK Therapeutics, Inc.
INKT
$11.90
$0.453.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.62M | 7.14M | 6.73M | 5.78M | 5.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -377.20K | -13.10K | -13.10K | 845.70K | 832.70K |
| Total Operating Expenses | 11.99M | 12.82M | 12.47M | 12.27M | 10.97M |
| Operating Income | -11.99M | -12.82M | -12.47M | -12.27M | -10.97M |
| Income Before Tax | -11.36M | -12.47M | -12.49M | -12.36M | -11.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.36 | -12.47 | -12.49 | -12.36 | -11.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.36M | -12.47M | -12.49M | -12.36M | -11.27M |
| EBIT | -11.99M | -12.82M | -12.47M | -12.27M | -10.97M |
| EBITDA | -11.83M | -12.66M | -12.29M | -12.07M | -10.76M |
| EPS Basic | -2.40 | -2.84 | -2.97 | -3.03 | -2.84 |
| Normalized Basic EPS | -1.50 | -1.78 | -1.83 | -1.87 | -1.75 |
| EPS Diluted | -2.40 | -2.84 | -2.97 | -3.03 | -2.84 |
| Normalized Diluted EPS | -1.50 | -1.78 | -1.83 | -1.87 | -1.75 |
| Average Basic Shares Outstanding | 18.95M | 17.91M | 17.08M | 16.35M | 15.86M |
| Average Diluted Shares Outstanding | 18.95M | 17.91M | 17.08M | 16.35M | 15.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |